Journal papers

• The PROPHET project paves the way for personalized prevention in the future healthcare. Kroese, M. et al. European Journal of Cancer Protection. 33(5):p 387-389, September 2024. https://doi.org/10.1097/cej.0000000000000873 

• High-fiedlity synthetic patient data applications and privacy considerations. Myles, P., Mitchell, C., Redrup Hill, E., Foschini, L., Wang, Z.. Journal of Data Protection & Privacy, Vol. 6, 4 (2024) https://doi.org/10.69554/LQOM5698
• Biomarkers for personalised prevention of chronic diseases: a common protocol for three rapid scoping reviews. Syst Rev 13, 147 (2024). Plans-Beriso, E., Babb de Villiers, C., Petrova, D. Turner, H., Blackburn, L. et al. https://doi.org/10.1186/s13643-024-02554-9
• A genomic perspective on climate change. EBioMedicine 98:104871. 2023. Forzano, F., Babb de Villiers C., Farley M., Fowler H., Taylor R.W. doi: 10.1016/j.ebiom.2023.10487
• The ethical challenges of diversifying genomic data: A qualitative evidence synthesis. Elizabeth Redrup Hill et al. Cambridge University Press. 2023 September. https://doi.org/10.1017/pcm.2023.20
• Ethical and legal implications of implementing risk algorithms for early detection and screening for oesophageal cancer, now and in the future. Tanya Brigden, Colin Mitchell, Elizabeth Redrup Hill and Alison Hall. PLOS ONE. 2023 October. https://doi.org/10.1371/journal.pone.0293576
• Ethical and legal considerations influencing human involvement in the implementation of artificial intelligence in a clinical pathway: A multi-stakeholder perspective. Elizabeth Redrup Hill, Colin Mitchell, Tanya Brigden and Alison Hall. Frontiers in Digital Health. 2023 March. https://doi.org/10.3389/fdgth.2023.1139210
• Public Preferences for Determining Eligibility for Screening in Risk-Stratified Cancer Screening Programs: A Discrete Choice Experiment. Dennison RA, Taylor LC, Morris S, Boscott RA, Harrison H, Moorthie SA, Rossi SH, Stewart GD, Usher-Smith JA. Med Decis Making. 2023 Feb 14:272989X231155790. doi: 10.1177/0272989X231155790. Online ahead of print
• Proactive breast cancer risk assessment in primary care: a review based on the principles of screening. Usher-Smith JA, Hindmarch S, French DP, Tischkowitz M, Moorthie S, Walter FM, Dennison RA, Stutzin Donoso F, Archer S, Taylor L, Emery J, Morris S, Easton DF, Antoniou AC.
  Br J Cancer. 2023 Feb 3:1-11. doi: 10.1038/s41416-023-02145-w. Online ahead of print.
• A Scoping Review of Approaches to Improving Quality of Data Relating to Health Inequalities. Moorthie S, Peacey V, Evans S, Phillips V, Roman-Urrestarazu A, Brayne C, Lafortune L.
  Int J Environ Res Public Health. 2022 Nov 29;19(23):15874. doi: 10.3390/ijerph192315874
• Secondary Use of Personal Health Data: When Is It “Further Processing” Under the GDPR, and What Are the Implications for Data Controllers?
  Becker, R., Chokoshvili, D., Comandé, G., Dove, E.S., Hall, A., Mitchell, C., Molnár-Gábor, F., Nicolàs, P., Tervo, S. and Thorogood, A., 2022. European Journal of Health Law, 1(aop), pp.1-29.
• Lessons from the pandemic for the future regulation of confidential patient information for research
  Colin Mitchell and Alison Hall. Journal of the Royal Society of Medicine. 2023;0(0).
• Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service
  Melissa Hill; Sian Ellard; Jane Fisher; Naomi Fulop; Marian Knight; Mark Kroese; Jean Ledger; Kerry Leeson-Beevers; Alec McEwan; Dominic McMullan; Laura Blackburn et al. [version 2; peer review: 2 approved]. NIHR Open Res 2022, 2:10
• Rapid systematic review to identify key barriers to access, linkage, and use of local authority administrative data for population health research, practice, and policy in the United Kingdom.
  Moorthie S, Hayat S, Zhang Y, Parkin K, Philips V, Bale A, Duschinsky R, Ford T, Moore A.
  BMC Public Health. 2022 Jun 28;22(1):1263. doi: 10.1186/s12889-022-13187-9.
• Applying GDPR roles and responsibilities to scientific data sharing
  Regina Becker, Adrian Thorogood, Jasper Bovenberg, Colin Mitchell, Alison Hall, International Data Privacy Law, Volume 12, Issue 3, August 2022, Pages 207–219
• A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening.
  Dennison R.A., Boscott R.A., Thomas R, Griffin S.J., Harrison H, John S.D., Moorthie S.A., Morris S, Rossi S.H., Stewart G.D., Thomas C.V., Usher-Smith J.A.. Health Expect. 8 May 2022.
• Towards implementation of comprehensive breast cancer risk prediction tools in health care for personalised prevention
  Moorthie S, Babb de Villiers C, Burton H, Kroese M, Antoniou A.C., Bhattacharjee P, Garcia-Closas M, Hall P, Schmidt M.K.. Preventive Medicine, Vol 159. 6 May 2022.
• Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors
  Schmutzler R.K., Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P, Balmaña J, Boccia S, Dabrock P, Emons G, Gaissmaier W, Gronwald J, Houwaart S, Huster S, Kast K, Katalinic A, Linn S.C., Moorthie S, Pharoah P,  Rhiem K, Spranger T, Stoppa-Lyonnet D, van Delden J.J.M., van den Bulcke M, Woopen C. Breast Care. April 2022.
• How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?
  Moorthie S, Hall A, Babb de Villiers C, Janus J, Brigden T, Blackburn L, Kroese M. Future Medicine. 15 March 2022.
• COVID-19 Research: Navigating the European General Data Protection Regulation
  Becker R, Thorogood A, Ordish J. Journal of Medical Internet Research Vol 22. No 8 (2020). 27 August 2020
• Understanding polygenic models, their development and the potential application of polygenic scores in healthcare
  Babb de Villiers C, Kroese M, Moorthie S. Journal of Medical Genetics Online First. 6 May 2020.
• Congenital disorders: epidemiological methods for answering calls for action
  Modell B, Darlison M.W, Malherbe H, Moorthie S, Blencowe H, Mahaini R, El-Adawy M.
  Journal of Community Genetics. 2018, Vol 9 issue 4, pp 335-340.
• An overview of concepts and approaches used in estimating the burden of congenital disorders globally
  Moorthie S, Blencowe H, Darlison M.W, Lawn J.E, Mastroiacovo P, Morris J.K, Modell B, Congenital Disorders Expert Group.
  Journal of Community Genetics. 2018; Volume 9, Issue 4, pp347-362.
• Methods to estimate access to care and the effect of interventions on the outcomes of congenital disorders
  Blencowe H, Moorthie S, Darlison M.W, Gibbons S, Modell B, Congenital Disorders Expert Group.
  Journal of Community Genetics. 2018; Volume 9 Issue 4, pp 363-376.
• Chromosomal disorders: estimating baseline birth prevalence and pregnancy outcomes worldwide
  Moorthie S, Blencowe, H, Darlison M.W, Gibbons S, Lawn J.E, Mastroiacovo P, Morris J.K, Modell B, Congenital Disorders Expert Group.
  Journal of Community Genetics. 2018; Volume 9 Issue 4, pp 377-386.
• Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide
  Moorthie S, Blencowe H, Darlison, M.W, Lawn J, Morris J.K, Modell, B, Congenital Disorders Expert Group.
  Journal of Community Genetics. 2018; Volume 9 Issue 4, pp 387-396.
• Genetic database software as medical devices
  Thorogood A, Touré S.B, Ordish J, Hall A, Knoppers B.
  Human Mutation. 2018; Vol. 39 Iss.11. pp1702-1712.
• AI for health: Is there a regulatory gap?
  Ordish J.
  Digital Health Legal. June 2018; Volume: 5 Issue: 6.
• Rare single gene disorders: estimating baseline prevalence and outcomes worldwide
  Blencowe H, Moorthie S, Petrou M, Hamamy H, Povey S, Bittles A, Gibbons S, Darlison M, Modell B, Congenital Disorders Expert Group
  Journal of Community Genetics. 2018; Volume 9 Issue 4, pp 397-406.
• A response to the forensic genetics policy initiative’s report “Establishing Best Practice for Forensic DNA Databases”
  Samuel, G, Howard H.C, Cornel M, van El C, Hall A, Forzano F, Prainsack B.
  Forensic Science International. 2018 5 July; Genetics (online).
• Risk stratification, genomic data and the law
  Hall A, Finnegan T, Susmita C et al.
  J Community Genet. 2018;9:195.
• Better governance, better access: practising responsible data sharing in the METADAC governance infrastructure.
  Murtagh M, B Mwenza, A Hall et al.
  Hum Genomics. 2018;12:24
• Risk stratification, genomic data and the law.
  Hall A, Finnegan T, Chowdhury S, Dent T, Kroese M, Burton H.
  J Community Genet. 2018; https://doi.org/10.1007/s12687-018-0358-4. [Epub ahead of print]
• Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis
  Belncowe H, Kancherla V, Moorthie S, et al.
  Annals of the New York Academy of Sciences. 2018 Jan 24; doi:10.1111/nyas.13548. [Epub ahead of print]
• An overview of concepts and approaches used in estimating the burden of congenital disorders globally
  Moorthie S, Blencowe H, W Darlison M, et al Congenital Disorders Expert Group.
  J Community Genet. 2017 Oct 11; doi: 10.1007/s12687-017-0335-3. [Epub ahead of print]
• Chromosomal disorders: estimating baseline birth prevalence and pregnancy outcomes worldwide.
  Moorthie S, Blencowe H, Darlison MW, et al, Congenital Disorders Expert Group.
  J Community Genet. 2017 Sep 26; doi: 10.1007/s12687-017-0336-2. [Epub ahead of print]
• Genomic medicine and data sharing
  Raza S, Hall A.
  Br Med Bull. 2017 Sep; 1;123(1):35-45.
• Exploring the potential duty of care in clinical genomics under UK law
  Mitchell C, Ploem C, Chico V, Ormondroyd E, Hall A, Wallace S, Fay M, Goodwin D, Bell J, Phillips S, Taylor J.C, Hennekam R, Kaye J.
  Medical Law International. 2017 Aug 14 [Epub ahead of print]
• Lacerda, EM. Nacul, L. Pheby, D. Shepherd, C. Spencer, P. Exploring the feasibility of establishing a disease-specific post-mortem tissue bank in the UK: a case study in ME/CFS Journal of Clinical Pathology. 2010;
  doi:10.1136/jcp.2010.082032
• Crawford G, Fenwick A, Foulds N, Hallowell N, Lucassen A. Genetic medicine and incidental findings: it is more complicated than deciding whether to disclose or not Journal of Medical Genetics. 2013 Nov;15(11):896-9
• Griffiths S, Hallowell N, Yeung Leung T, Yi H. Motivations for Undertaking a DNA Sequencing-Based Non-Invasive Prenatal Testing for Fetal Aneuploidy: Qualitative Study with Early Adopter Patients in Hong Kong PLOS One. 2013 Nov 27
• Preconception Healthcare and Congenital Disorders: Systematic Review of the Effectiveness of Preconception Care Programs in the Prevention of Congenital Disorders
  Alberg C, Nacul L, Pashayan N, Shannon G.
  Matern Child Health J. 2013 Oct 4.
• What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
  Chowdhury S, Hall A, Pashayan N, Pharoah P.
  Journal of Medical Ethics. 2013 Mar 1 [Epub ahead of print] PubMed PMID: 23454719
• Big data or bust – realising the microbial genomics revolution
  Luheshi L, Raza S.
  Microbial Genomics. 18 December 2015; 10.1099/mgen.0.000046
• Preconception Healthcare Delivery at a Population Level: Construction of Public Health Models of Preconception Care
  Alberg C, Nacul L, Pashayan N, Shannon G.
  Matern Child Health J. 2013 Nov 14.
• Ethical issues and best practice in clinically based genomic research: Exeter Stakeholders Meeting Report
  Bewshea C, Carrieri D, Hall A, Walker G.
  J Med Ethics doi:10.1136/medethics-2016-103530
• Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down’s syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units
  Chitty LS, Wright D, Kroese M. et al
  BMJ. 2016 Jul 4;354:i3426.
• Responsible implementation of expanded carrier screening
  Henneman L, Borry P, Hall A.
  Eur J Hum Genet. 2016 Jun; 24(6)w1-e12.
• Systematic Review and Meta-analysis of the Birth Prevalence of Orofacial Clefts in Low and Middle Income Countries
  Kadir A, Mossey PA, Blencowe H, Moorthie S et al.
  Cleft Palate Caniofac J. 2016 Jul 19 [Epub ahead of print]
• Association of Vasomotor and Other Menopausal Symptoms with Risk of Cardiovascular Disease: A systematic Review and Meta-Analysis
  Muka T, Oliver-Williams C, Chowdhury S et al.
  PloS One. 2016 Jun 17; 11(6):e0157417.
• Known unknowns: building an ethics of uncertainty into genomic medicine
  Gaff C, Hall A, Leonard S, Newson A.
  BMC Medical Genomics (2016) 9:57 DOI 10.1186/s12920-016-0219-0
• Implications of using whole genome sequencing to test unselected populations for high risk breast cancer genes: a modelling study
  Warren-Gash C, Kroese M, Burton H, Pharoah P.
  Hered Cancer Clin Pract. 2016 Jun; 1;14:12.
• Preparing clinicians for genomic medicine
  Burton H, Slade I.
  Postgrad Med J. 2016 Jul;92(1089):369-71. doi: 10.1136/postgradmedj-2016-133962. Epub 2016 Mar 21.
• Pathogen genomics into practice: from promising research to real health impact
  Moorthie S, Luheshi L.
  Microbiology Today. 2016 February; 43:1.
• Moving pathogen genomics out of the lab and into the clinic: what will it take?
  Luheshi L, Peacock S, Raza S.
  Genome Medicine. 30 December 2015; DOI: 10.1186/s13073-015-0254-z
• Realising the promise of non-invasive prenatal testing
  Chitty LS, Kroese M.
  BMJ. 2015 Apr 10;350:1792.
• Cost Effectiveness of Using Array-CGH for Diagnosing Learning Disability
  Sagoo GS, Mohammed S, Barton G, Kroese M et al.
  Applied Health Economics and Health Policy. 2015; 13,4, 421-432.
• Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening
  de Wert G, Dondorp W, Hall A.
  European Journal of Human Genetics. 2015 March 18.
• Considerations in establishing a post-mortem brain and tissue bank for the study of myalgic encephalomyelitis/chronic fatigue syndrome: a proposed protocol
  Bowman E, Goldring K, Gveric D, Hall A, Lacerda E, Nacul L, O’Donovan D, Pheby D.
  BMC Research Notes. 2014; (7):370.
• Personalized medicine: what’s in a name?
  Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G, Stewart A.
  Personalised Medicine. 2014; 11(2):197-210.
• Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases
  Moorthie S, Cameron L, Sagoo G, Bonham J, Burton H.
  Journal of Inherited Metabolic Disease. 2014 Nov; 37(6):889-898.
• The impact of genetics on public health practice
  Abubakar I, Burton H, Jackson C.
  British Medical Bulletin. 2014 Oct; 112(1):37-46.
• Points to consider for prioritizing clinical genetic testing services: a European consensus process oriented accountability for reasonableness
  Borry P, Cornel M, Kroese M, Severin F.
  European Journal of Human Genetics. 2014 Sept 24.
• Beyond public health genomics: proposals from an international working group
  Boccia S, Mc Kee M, Adany R, Boffetta P, Burton H, Cambon-Thomsen A, Cornel MC, Gray M, Jani A, Knoppers BM, Khoury MJ, Meslin EM, Van Dijn CM, Villari P, Zimmern R, Cesario A, Puggina A, Colotto M, Ricciardi W.
  Eur J Public Health. 2014 Dec; 24(6):877-9.
• Revealing the results of whole-genome sequencing and whole-exome sequencing in research and clinical investigations: some ethical issues
  Alberg C, Hall A, Hallowell N, Zimmern R.
  Journal of Medical Ethics. Epub 2014 Jul 18.
• Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol
  Boustred C, Chitty L, Daley R, Fisher J, Hill M, Howarth A, Kroese M, Lench N, Lewis C, Lo K, Mason S, Mckay F, Morris S, Plagnol V, Spencer K, Wright D.
  BMC Pregnancy Childbirth. 2014 Jul 16; 14:229.
• From the lab to the maternity ward: how genetics can beat birth defects
  Brice P.
  The Guardian. 2014 July 9.
• A Toolkit to assess health needs for congenital disorders in low- and middle-income countries: an instrument for public health action
  Nacul L,Stewart A, Alberg C, Chowdhury S, Burton H, Darlison MW, Grollman C, Hall A, Modell B, Moorthie S,  Sagoo G, .
  Journal of Public Health. 2014 June; 36(2):243-50. doi: 10.1093/pubmed/fdt048 : May 10, 2013 [Epub ahead of print]
• Bahl R, Lawn J, Wall S. Newborn health research priorities beyond 2015 The Lancet. 2014 July 12;384(9938):e27-e29.
• Preconception healthcare and congenital disorders: Systematic Review of the effectiveness of preconception care programs in the prevention of congenital disorders
  Alberg C, Nacul L, Pashayan N, Shannon G.
  Maternal and Child Health Journal. 2014 August; 18(6):1354-79.
• Personalised medicine in the UK: challenges of implementation and impact on healthcare system
  Burton H, Hall A, Kroese M, Pokorska-Bocci A, Sagoo G.
  Genome Medicine. 2014 Apr 25; 6(4):28.
• What ethical and legal principles should guide the genotyping of children as part of a personalised screening programme for common cancer?
  Burton H, Chowdhury S, Hall A, Pashayan N, Pharoah P.
  Journal of Medical Ethics. 2014 Mar; 40(3):163-7.
• Issues concerning the evaluation and regulation of predictive genetic testing
  Zimmern R.
  J Community Genet. 2014 Jan; 5(1):49-57.
• Familial Hypercholesterolaemia: a pressing issue for European health care
  Aitman T, Brice P, Burton H, Edwards C, Humphries S.
  Atherosclerosis. 2013 December; 231(2): 223-226
• Recommendations for returning genomic incidental findings? We need to talk!
  Bennett R, Botkin J, Burke W, Clayton E, Henderson G, Holm I, Jarvik G, Khoury M, Knoppers B, Matheny A, Press N, Ross L, Rothstein M, Saal H, Uhlmann W, Wilfond B, Wolf S, Zimmern R.
  Genet Medicine. 2013 Nov; 15(11):854-9.
• Public health genomics and personalised prevention: lessons from the COGS project
  Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
  Journal of Internal Medicine. 2013 Nov; 274(5):451-6
• Policy challenges of clinical genome sequencing
  Birney E, Burton H, Cunningham F, Firth H, Hurst J, Middleton A, Wright C.
  British Medical Journal. 2013 Nov 22; 347:f6845.
• Life insurance: genomic stratification and risk classification
  Burton H, Chowdhury S, Dent T, Feze I, Foulkes W, Hall A, Hamet P, Joly Y, Kirwan N, Knoppers B, Macdonald A, Pashayan N, Simard J, Van Hoyweghen I.
  European Journal of Human Genetics. 2013 Oct 16. doi: 10.1038/ejhg.2013.228
• Health needs assessment for congenital anomalies in middle-income countries: Examining the case for neural tube defects in Brazil
  Schuler-Faccini L, Sanseverino M, de Rocha Azevedo L, Moorthie S, Alberg C, Burton H, Chowdhury S, Sagoo G, Nacul L.
  J Community Genet. 2013 Aug 30. [Epub ahead of print]
• Implementing risk-stratified screening for common cancers: a review of potential ethical, legal and social issues
  Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
  Journal of Public Health (Oxf). 2013 Aug 28.
• Systematic review of birth prevalence of neural tube defects in India
  Bhide P, Sagoo G, Moorthie S.
  Birth Defects Res A Clin Mol Teratol. 2013 Jul; 97(7):437-43.
• Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations
  Christianson A, Zimmern R.
  J Community Genet. 2013 Jun 23 [Epub ahead of print] PMID: 23794314
• Finnegan, Tom. Harvey, Kate. Jagadesham, Varsha. Joynson, Catherine. Mills, Peter. Perkins, Carol. Riley, Laura. Svenning Berg, Ranveig. Walker-Robson, Sarah. White, Johanna. Whittall, Hugh. Wright, Katharine.. Review of the Nuffield Council on Bioethics Report: Novel Techniques for the prevention of mitochondrial DNA disorders: an ethical review Genomics, Society and Policy 8:29-31 (2013)
• Preconception health care and congenital disorders: mathematical modelling of the impact of a preconception care programme on congenital disorders
  Alberg C, Nacul L, Pashayan N, Shannon G.
  BJOG. 2013 Apr; 120(5):555-66. doi: 10.1111/1471-0528.12116. Epub 2013 Jan 18.
• Alsop K, Bowtell D, Crook A, Gleeson M, Hallowell N, Mitchell G, Plunkett L. The responses of research participants and their next of kin to receiving feedback of genetic test results following participation in the Australian Ovarian Cancer Study Genetics in Medicine. 2013; 15:458-465
• Public health implications from COGS and potential for risk stratification and screening
  Burton H, Chowdhury S, Dent T, Hall A, Pashayan N, Pharoah P.
  Nature Genetics. 2013 Apr; 45(4):349-51 doi: 10.1038/ng.2582. PubMed PMID: 23535723
• Informatics and clinical genome sequencing: opening the black box
  Moorthie S, Hall A, Wright C.
  Genet Medicine. 2013 Mar; 15(3):165-71.
• Incorporating genomics into breast and prostate cancer screening: assessing the implications
  Burton H, Chowdhury S, Dent T, Hall A, Hall P, Lyratzopoulos G, Pashayan N, Pharoah P.
  Genetics in Medicine. 2013 Feb 14 doi: 10.1038/gim.2012.167. [Epub ahead of print] PubMed PMID: 23412607.
• The use of a toolkit for health needs assessment on neural tube defects in Argentina
  Groisman B,  Liascovich R, Barbero P, Alberg C, Moorthie S, Nacul L,  Sagoo G.
  J Community Genet. 2013 Jan; 4(1):77-86.
• Stratified cancer screening: the practicalities of implementation.
  Burton H, Chowdhury S, Dent T, Eccles D, Eeles R, Hall A, Jbilou J, Lyratzopoulos G, Pashayan N, Pharoah P, Rafi I, Segnan N, T.
  Public Health Genomics. 2013;16(3):94-9.
• Next-generation sequencing in the clinic: are we ready?
  Biesecker L, Burke W, Kohane I, Plon S, Zimmern R.
  Nat Rev Genet. 2012 Nov; 13(11):818-24. doi: 10.1038/nrg3357
• Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis
  Higgins J, Sagoo G, Wei Y, Wright C.
  BMC Res Notes. 2012 Sep; 1;5:476.
• The impact of genomics on public health practice: the case for change
  Khoury M, Zimmern R.
  Public Health Genomics. 2012; 15(3-4):118-24.
• Bellingan L, Bellingham J, Sutherland W. A collaboratively-derived science-policy research agenda PLoS One. 2012;7(3):e31824
• Brayne C, Dent T, Janssens A, Stephan B, Wright C. Risk Prediction Models: a framework for assessment Public Health Genomics. 2012; 15(2):98-105
• Zenner D. Predictive power of Koplik’s spots for the diagnosis of measles Journal of Infection in Developing Countries. 2, 2012; 6(3):271-275
• The impact of whole genome sequencing on the NHS and population healthPokorska-Bocci A.
  British Society for Human Genetics. Jan 2012; Newsletter No 46.
• End of the Beginning and Public Health Pharmacogenomics: Knowledge in ‘Mode 2’ and P5 Medicine1
  Burton H, Dove E, Fisher E, Masellis M, Ozdemir V, Warnich L, Wright C.
  Current Pharmacogenomics and Personalized Medicine. 2012 Jan 1; 10(1);1-6.
• Genomics and individuals in public health practice: are we luddites or can we meet the challenge?
  Zimmern R.
  Journal of Public Health (Oxf). 2011 Dec; 33(4):477-82.
• Review of Massively Parallel DNA sequencing technologies
  Mattocks C, Moorthie S, Wright C.
  The HUGO Journal. 2011.
• Inherited cardiomyopathies
  Alberg C, Behr E, Burton H, Raju H, Sagoo G.
  British Medical Journal. 2011 Nov 21; 343:d6966. doi: 10.1136/bmj.d6966
• Personalised Medicine: Lessons from Birth Defects and Single Gene Disorders
  Burton H, Sanderson S.
  Current Pharmacogenetics & Personalised Medicine. 2011; 9(2): 80-83.
• Dent T, Greenhalgh T, Mathur R, Meads C, Noble D. Risk models and scores for type 2 diabetes: systematic review British Medical Journal. 2011;343:d7163
• Dent T. Educating about risk scores in primary care Education for Primary Care. 2011; 22: 291-292
• Pashayan N, Pharoah P. Translating genomics into improved population screening – hype or hope? Human Genetics. 2011; doi:10.1007/s00439-011-0985-x
• Campion P, Drachler M, Fayyaz S, Howe A, Leite J, Molokhia M, Poland F. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care BMC Medicine. 2011, 9:91 (28 July 2011)